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Background: This study investigated a possible role of Escherichia coli in propagation and perpetuation of the
chronic inflammation in ulcerative colitis (UC). The lesions of UC are located superficially on the rectal and/or
colonic mucosa. It is suggested that the commensal bacteria of the digestive tract may play a role in the
pathogenesis of UC. Several studies have demonstrated proliferation of E. coli in the gut of UC patients. An increase
in the number of E. coli in the inflamed tissue is most probably related to the abundance of iron ions produced by
the bacteria.
Methods: Colon mucosal biopsies were collected from 30 patients with acute-phase UC, both from tissues with
inflammatory changes (n = 30) and unchanged tissue with no inflammatory changes (n = 30) from the same
patient. Biopsies were also taken from 16 patients with irritable bowel syndrome diarrhea who comprised the
control group. Quantitative and qualitative analysis of the biopsy specimens was performed using culture methods
and real-time polymerase chain reaction (PCR). Genotyping of the E. coli isolates was done using pulsed-field gel
electrophoresis. Multiplex PCR was used to compare the E. coli strains for the presence of genes responsible for
synthesis of iron acquisition proteins: iroN, iutA, iha, ireA, chuA, and hlyA.
Results: We demonstrated that there was a significant increase in the number of E. coli at the sites of inflammation
in patients with UC compared to the control group (P = 0.031). Comparative analysis of the restriction patterns of
E. coli isolated from inflammatory and unchanged tissues showed that the local inflammatory changes did not
promote specific E. coli strains. There was a significant difference in the frequency of the iroN gene in E. coli isolated
from patients with UC as compared to the control group.
Conclusions: The increase in the numbers of E. coli in the inflammatory tissues is related to the presence of chuA
and iutA genes, which facilitate iron acquisition during chronic intestinal inflammatory processes.
Keywords: Ulcerative colitis, Escherichia coli, Iron acquisitionBackground
Ulcerative colitis (UC) is a chronic inflammatory disease
and, like Crohn’s disease, belongs to the inflammatory
bowel diseases (IBDs) [1,2]. The lesions of UC are lo-
cated superficially on the rectal and/or colonic mucosa.
The clinical course of UC is most commonly composed
of exacerbation with periodic remission [3]. Disease* Correspondence: mbstrus@cyf-kr.edu.pl
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distribution, and reproduction in any mediumactivity is assessed based on medical history, as well as
endoscopic changes in the large intestine [4].
Initial studies on the microbiology of UC were directed
toward determination of a single etiological agent respon-
sible for the development of IBD. Particular attention was
paid to bacteria such as Salmonella, Shigella, Campylobac-
ter, Listeria and Mycobacterium and their possible role in
the inflammatory processes in the gastrointestinal (GI) tract
[5,6]. None of the studies showed any increase in the popu-
lations of the above bacteria in the course of the disease.
Currently, it is suggested that commensal bacteria of theCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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nesis of UC [2,7].
Several studies have demonstrated the proliferation of
Escherichia coli in the gut of animal models and UC pa-
tients [2,8,9]. Studies performed on knockout mouse
models (129/SvEv) have shown that chronic gut inflam-
mation in IL-10−/− mice results in a reduction of gut
microbiota diversity and a strong increase in intestinal
E. coli [10].
The increase in the number of E. coli in the inflamma-
tory tissue is most probably related to the abundance of
iron ions available for siderophores produced by the bac-
teria [11]. Therefore, the significant increase in E. coli,
but not their high virulence, may have an influence on
the inflammatory process in the GI tract.
For E. coli that colonizes the human colon, it is im-
portant to have sufficient iron in the cells. In the process
of acquiring iron ions, it is necessary for the cell to be
able to produce transmembrane proteins that play a re-
ceptor role for siderophores that chelate iron ions. The
receptor protein for hemin, which allows bacteria to use
iron from heme, is coded by the chuA gene; synthesis of
the receptor protein for phenol-derived siderophores is
dependent on the iron gene; the protein that is an analog
of the adhesion-forming part of the outer membrane is
coded by the iha gene; and outer membrane proteins in-
volved in binding other siderophores are coded by the
iutA and ireA genes. Among E. coli strains isolated from
patients suffering from diseases of the GI tract, strains
that have the ability to lyse erythrocytes have been iden-
tified, with hemolysin α being the best characterized.
Biosynthesis of the active form of the enzyme requires
hlyC, hlyA, hlyB and hlyD genes, post-translational
modification, and secretion by protein translocators
[12,13].
There are reports that some E. coli genotypes are more
likely associated with IBD than others [14]. In particular,
E. coli strains belonging to phylogenetic groups associated
with virulence genes and the ability to adhere to and in-
vade host cells are more frequently isolated from IBD pa-
tients than from control subjects [9,15]. So far there has
been no universal agreement as to which specific features
are responsible for their dominance.
Studies on animal models [10] have not shown a clear-
cut correlation between increases in E. coli cell numbers
and the severity of inflammation, which supports the as-
sumption that high E. coli numbers are a consequence
rather than a cause of disease. Furthermore, it has been
shown that nonpathogenic E. coli strains even accelerate
remission [16].
The aims of the present study were: (1) quantitative
assessment of most important bacterial groups, with spe-
cial emphasis on E. coli in patients with the active phase
of UC, in sites of inflammatory changes and unchangedmucosa, as well as in the control group, based on cul-
ture methods and real-time polymerase chain reaction
(PCR); (2) comparative genotyping of E. coli strains iso-
lated from the same patients with active-phase UC from
inflammatory and unchanged mucosa; and (3) compari-
son of the frequency of genes present, which are respon-
sible for production of factors that facilitate iron ion
acquisition (iroN, iutA, iha, ireA, chuA and hlyA).
Methods
Study subjects
The study material consisted of biopsies collected during
colonoscopy from the colon mucosa of 30 patients with
a diagnosis of acute-phase UC and from 16 patients with
irritable bowel syndrome diarrhea who comprised the
control group. The study was performed in the Clinic of
Gastroenterology and Hepatology of the University Hos-
pital in Cracow and in the Microbial Ecology Laboratory
of the Chair of Microbiology, Jagiellonian University in
2008–2011, after approval by the Jagiellonian University
Bioethical Committee (no. KBET/75/B from 15.11.2007).
Informed consent was obtained from all patients partici-
pating in the study.
The average age of patients with UC was 42 ± 11 years,
and the average disease duration was 5 years (1–23 years),
with an average exacerbation rate of 1.5/year. Activity of
UC and exacerbation of endoscopic changes in the colon
were based on the Mayo Clinic Disease Activity Index [4].
All subjects underwent the same type of preparation prior
to colonoscopy, with oral sodium phosphate at a dose of
0.6–0.8 ml/kg (up to 45 ml) and bowel cleansing, con-
sisting of four saline enemas. During colonoscopy, patients
received intravenous sedation or general anesthesia, as re-
quired. Two biopsy specimens were collected from each
patient with UC: one from the colonic mucosa with in-
flammatory changes (Sample A, n = 30); and the other
from mucosa with no inflammatory signs (Sample B,
n = 30). Inflammatory tissue was characterized during col-
onoscopy by disappearance of the vascular network, fra-
gile mucosa with bleeding on contact, ulcerations,
erosions, and sometimes pseudopolyps. The unaffected
tissue showed normal mucosa with visible blood vessels,
with no redness or mucosal depletion in the form of ulcers
or erosions. In patients from the control group, no inflam-
matory changes were noted in the colon mucosa and only
single biopsies were collected (Sample C, n = 16). All
tissues were subjected to histopathological assessment
according to the Geboes scale [17]. The unaffected tissue
from UC patients and mucosa from the control group re-
ceived zero points according to the scale. The exclusion
criteria were: diabetes, autoimmune disorders, severe sys-
temic diseases, alcohol abuse, cow’s milk allergy, and non-
steroidal anti-inflammatory drugs intake. All patients
enrolled in the study received no antibiotics for at least 3
Table 1 Primers and probes used in this study
Gene Product
size [bp]
Oligonucleotide sequence
hlyA 1177 GTA TAC ACA AAA GAA GGA AGC
ACA GAA TCG TCA GCA TCA GC
iroN 667 AAG TCA AAG CAG GGG TTG CCC G
GACGCCGACATTAAGACGCAG
iutA 302 GGC TGG ACA TCA TGG GAA CTG G
CGT CGG GAA CGG GTA GAA TCG
iha 829 CTG GCG GAG GCT CTG AGA TCA
TCC TTA AGC TCC CGC GGC TGA
ireA 254 GAT GAC TCA GCC ACG GGT AA
CCA GGA CTCA CCT CAC GAA T
chuA 279 GAC GAA CCA ACG GTC AGG AT
TGC CGC CAG TAC CAA AGA CA
Primers and probe specific for E. coli strains (Real-time PCR)
16S rRNA 204 GGG AGT AAA GTT AAT ACC TTT GC
CTC AAG CTT GCC AGT ATC AG
Probe HEX- CGC GAT CAC TCC GTG CCA GCA GCC
GCG GAT CGC G -BHQ1
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received standard treatment with 3 g/day mesalamine.
Qualitative and quantitative identification of bacterial
species
Culture methods
The collected biopsies were suspended in Schaedler
broth (SAB; Difco, USA) with 10% glycerol and stored at
−20°C for up to 1 week. The samples were transported
to the microbiology laboratory on dry ice. The frozen
samples were thawed, weighed, homogenized in 1 ml
SAB, and quantitatively analyzed for the main bacterial
constituents by culture on differential media in aerobic
and anaerobic conditions [18]. All these manipulations
were done aseptically in an anaerobic chamber (MACS;
Don Whitley, Shipley, Yorks, UK) in an atmosphere of
N (85%) + H2 (10%) + CO2 (5%). Homogenized sam-
ples were serially diluted with SAB and 100-μl aliquots
were plated on the following media: McConkey Agar
(Oxoid, Basingstoke, Hants, UK) for Enterobacteriaceae;
Columbia Blood Agar (Difco) with 5% sheep blood for
streptococci; BBL Enterococcosel Agar (BD, Franklin
Lakes, NJ, USA) for enterococci; MRS Agar (Oxoid) for
lactobacilli and other lactic acid bacteria; BL Agar for
bifidobacteria; and Wilkins–Chalgren Agar Base with
supplements for Bacteroides [19]. The morphology of
the colonies was analyzed under a magnifying glass and
several colonies (7–10) of each morphological type were
subcultured on appropriate aerobic and anaerobic media
and Gram stained. After further incubation and culture
purity checks, phenotypic identification was performed
using commercial identification systems (API 20E, API
20A, API Staph, and API Strept; bioMerieux, Marcy
l’Etoile, France; BBL Crystal ID System; BD). To verify
speciation, all Gram-negative rods tested with API 20E
were additionally analyzed with PCR with species-
specific primers for E. coli [20]. The numbers of colonies
of the bacterial groups and the sum of the cultured bac-
teria in the weighed tissue samples were converted into
1 g of the mass to make the quantitative comparisons
among the patients.
Real-time PCR
Real-time PCR was used to verify the results obtained
with culture methods. DNA extraction from all tissue
samples was performed using the Genomic Mini Isola-
tion Kit (A&A Biotechnology, Poland), according to the
manufacturer’s recommendations, with our own modi-
fication. After lysis of the bacterial cells with lysozyme
(1 mg/ml) and lysostaphin (0.1 mg/ml), samples were in-
cubated at 37°C for 20 min. Next, 200 μl 75 mM NaOH
(50 mM) was added and samples were incubated at 95°C
for 10 min. After incubation, probes were microcentri-
fuged (12 000 rpm, 10 min), supernatants were removed,and pelets were resuspended in 500 μl buffer sup-
lemented with β-mercaptoethanol (Sigma). For each
sample, lyticase was added (0.1 mg/ml). Probes were in-
cubated at 37°C for at least 30 min and microcentrifuged
(12 000 rpm, 10 min). The next steps of DNA extraction
were carried out according to A&A Biotechnology’s
procedure.
To detect specific DNA sequences after extraction,
fluorescently labeled probes and pairs of specific primers
were used (Table 1). E. coli in the corresponding tissue
samples was quantified by Real-Time PCR, as described
previously [21]. A standard curve was prepared. DNA
from given numbers of E. coli was added in serial dilu-
tions from 101 to 108 cells to a series of PCRs. The reac-
tions were carried out in a BioRad thermocycler, and the
fluorescence was monitored throughout the reaction.
The results are shown in Figure 1. A standard curve
from these data is shown in Figure 2. Detection and
quantitation were linear over the range of DNA concen-
trations examined. To determine the number of E. coli
cells, the fluorescent signals detected from two serial di-
lutions in the linear range of the assay were averaged
and compared to a standard curve (Figure 2).
Genotyping of E. coli using pulsed-field gel
electrophoresis (PFGE)
To genotype and compare E. coli strains isolated from
the inflammatory and unchanged tissues from the same
patient, we performed comparative analysis using PFGE.
Preparation of the agarose blocks, conditions of
Figure 1 Relative fluorescence is the increase in reporter dye intensity relative to the passive internal reference dye. The amount of
E. coli DNA in each sample is shown in the key. The threshold fluorescence, or level at which the threshold cycle was determined, is shown.
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rameters were carried out according to the international
PulseNet CDC (PulseNet 2002) guidelines [22]. The ref-
erence strain − Salmonella Braenderup H9812 – was
obtained by courtesy of the staff of the National Institute
of Public Health – National Institute of Hygiene in
Warsaw. PFGE banding patterns were analyzed with the
Molecular Analyst software (BioRad) using Dice coeffi-
cient and UPGMA (unweighted pair group method with
arithmetic averages) algorithm.Multiplex PCR
When choosing genes for PCR, we concentrated on the
property of E. coli to acquire iron ions, that is: iroN,
iutA, ireA and chuA genes coding receptor proteins for
siderophores; iha coding the protein analog of adhesin;
and hlyA gene responsible for hemolysin α synthesis, the
enzyme that degrades erythrocytes and liberates hemin.
Multiplex PCR was performed according to the method
of Zhao et al. [23] and PCR following the procedure ofFigure 2 Standard curve was generated from the amplification plot in
Threshold cycle was the cycle number when the threshold fluorescence wAranda et al. [24]. Primer sequences and the size of the
amplification products are shown in Table 1.
Detection of hemolytic activity
All isolated E. coli strains were tested for the production
of hemolysin on blood agar plates, prepared with defi-
brinated sheep blood washed three times and added to
Trypticase Soy Agar (Columbia Lab Agar; Biocorp) at a
final concentration of 5%. Production of hemolysis was
characterized by the formation of a clear halo around
bacterial colonies after overnight incubation at 37°C.
The absence of hemolytic activity characterized nonhe-
molytic E. coli strains.
Evaluation of relations between numbers of E. coli
expressing iroN, iutA, iha, ireA, chuA and hlyA and their
isolation sites
To obtain a general model for the factors influencing the
number of bacteria, a multivariate statistical model was
constructed. The model was based on the general linear
model assumption. Bacterial abundance was assumed toFigure 1. y= −1.377 ln(x) + 43.063; correlation coefficient =0.996.
as reached.
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dependent on the set of categorical predictors: absence
of the analyzed genes (iroN, iutA, iha, ireA, chuA and
hlyA); group of patients; and the site of material origin.Statistical analysis
Statistical analysis was done using Microsoft Access and
Statistica software packages. Likelihood ratio and χ2 tests
were used. P < 0.05 was considered significant. The
model used to evaluate the relations between the num-
bers of E. coli expressing the different genes and their
isolation sites significantly explained the statistical rela-
tions (χ2 = 65,2614, df = 8, P < 0.0001).Results
Qualitative and quantitative assessment of bacterial
species based on culture methods
Based on classical culture methods, we showed that
there were significantly more lactobacilli in the inflam-
matory tissues (Sample A) compared to the control
group (P = 0.044), and in the noninflammatory mucosa
(Sample B) compared to the control group (P = 0.041).
There were no significant differences in the numbers of
Enterococcus, Streptococcus and Bifidobacterium isola-
ted from inflammatory and unchanged tissues in pa-
tients with UC compared with the control group. For
Enterobacteriacae with special consideration of E. coli,
no quantitative differences were observed between the
UC patients and control group. The results are shown in
Table 2.
Based on culture methods, 52 E. coli strains were iso-
lated from 18 patients with acute-phase UC: 25 strains
from Samples A, 27 strains from Samples B, and 18
strains from 12 patients in the control group. In total, 70
E. coli strains were investigated further.Table 2 Numbers of bacteria isolated from inflammatory and
Bacteria Average bacterial no. [c.f.u/g] isolated fr
Inflammatorily changed site biopsy
(sample A, n=30)
Sume of cultured bacteria 3.1·107±1.6·107
Enterobacteriaceaae 5.0·106±1.8·106
Escherichia coli *** 3.3·106±3.1·106
Enterococcus 8.9·106±6.3·106
Streptococcus 3.2·106±2.0·106
Lactobacillus 5.2·106 ±3.0·106*
Bifidobacterium 5.1·106±3.5·106
Results based on culture methods.
* Numbers significantly different from the control group (*P = 0.044; **P = 0.041).
*** E. coli was found in only 18 patients with active-phase UC and 12 patients fromQuantitative assessment of E. coli based on real-time PCR
The bacterial DNA sequences isolated from all 76 tissue
samples were analyzed. The presence of E. coli DNA was
confirmed in 48 tissue samples (including 36 samples from
18 patients with acute-phase UC: Sample A, n = 18; Sam-
ple B, n = 18; and from 12 patients in the control group,
Sample C, n = 12. There was a significant increase in the
E. coli populations in the inflammatory tissues (Sample A)
from patients with UC compared with the control group
(P = 0.031), but not in the non-inflammatory tissues
(Sample B). The results are shown in Table 3.PGFE genotyping of E. coli isolated from inflammatory
and unaffected tissues in patients with active-phase UC
Isolated E. coli strains were characterized by high genetic
variability. The analyses were done for all patients with
confirmed E. coli strains (n = 18), including 52 strains
originating from Samples A (25 strains) and Samples B
(27 strains). Among the 52 strains, 32 different pulsotypes
were noted. In 15 patients (83%), the E. coli strains isolated
from inflammatory and unchanged tissues had identical
restriction profiles. Only three patients had genetically dif-
ferent strains isolated from Sample A vs. Sample B. Addi-
tionally, in eight patients there was more than one E. coli
strain isolated from the given site with a unique genetic
profile. The results are shown in Figure 3.Frequency of genes responsible for synthesis of proteins
for acquisition of iron ions
Based on PCR, we tested for the frequency of genes in
the genomes of 70E. coli strains. Analyzing the frequency
of the genes responsible for synthesis of proteins for ac-
quisition of iron ions (iroN, iutA, iha, ireA, chuA and
hlyA), we showed significant differences in relation to
the frequency of iroN gene coding the protein respon-
sible for binding siderophores. The iroN gene wasunchanged colonic mucosa in patients with UC
om patients in active phase of UC, n=30 Control group,
(sample C, n=16)Unchanged mucosal biopsy
(sample B, n=30)
6.4·107±4.8·107 7.6·107±6.1·107
2.1·107±1.1·107 1.5·107±8.1·106
1.3·106±1.1·106 1.6·106±1.2·106
9.5·106±4.5·106 4.5·106±3.4·106
9.1·106±6.8·106 7.1·106±5.9·106
8.5·106±5.0·106 ** 7.6·105±4.4·105
2.1·106±1.1·106 2.7·105±1.2·105
the control group.
Table 3 Numbers of bacteria isolated from inflammatory and unchanged colonic mucosa in patients with UC
Bacteria Average bacterial no. [c.f.u/g] isolated from patients in active phase of UC, n=30 Control group,
(sample C, n=16)Inflammatorily changed site biopsy
(sample A, n=30)
Unchanged mucosal biopsy
(sample B, n=30)
Escherichia coli *** 3.95·1013±3.9·1013* 2.21·1010±3.1·1010 9.17·1010±6.5·1010
Results based on Real-time PCR.
* Numbers significantly different from the control group (*P = 0.031).
*** E. coli was found in only 18 patients with active-phase UC and 12 patients in the control group.
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ples A (inflammatory tissue); in 18 of 27 strains isolated
from Samples B (unchanged tissue); as well as in six of
18 strains isolated from patients in the control group. A
higher number of E. coli isolates from UC patients had
the iroN gene in comparison with the strains isolated
from the control group. No significant differences were
shown for the frequency of the iroN gene in the strains
from Samples A and B from the same patient. The re-
sults are shown in Table 4 and Figure 4.
Detection of hemolytic activity
When analyzing the ability of E. coli to lyse red blood
cells, 10 of 70 strains cultured on blood agar showed
phenotypic hemolytic characteristics. α-Hemolysis in se-
lected strains is shown in Figure 5. Furthermore, 70 E.
coli strains were tested with PCR to confirm the pres-
ence of the hlyA gene, which is responsible for biosyn-
thesis of α-hemolysin. In 10 strains that showed
phenotypic α hemolysis, the presence of hlyA was con-
firmed. These strains were isolated with the same fre-
quency from inflammatory and unchanged tissues.
Relations between numbers of E. coli expressing iroN,
iutA, iha, ireA, chuA and hlyA and their isolation sites
Analysis showed that three predictors significantly
influenced the dependent variable: presence of genes
chuA and iutA as well as place of origin (inflammatory
colonic mucosa, Sample A and unchanged mucosa,
Sample B). Presence of chuA and iutA genes in E. coli
correlated with the increase in bacteria assessed using
real-time PCR in the inflammatory tissues where there
was more free iron available.
Discussion
Currently, a lot of attention is given to the role of com-
mensal bacteria in the human GI tract, the numbers of
which change in relation to persistent intestinal inflam-
matory processes [2,7-9,25].
Mylonaki et al. have shown a significant increase in the
population of E. coli from colonic mucosa biopsies collected
from UC patients compared with those in remission and
the control group [26]. Kleessen at al. [27] have analyzed
quantitative changes in bacterial populations in patients
with UC versus a control group, and demonstrated anincrease in the populations of Enterobacteriacae, including
E. coli. In both studies, the quantitative analysis was based
on fluorescence in situ hybridization (FISH).
We confirmed the relationship between an increase in
the population of Gram-negative rods (E. coli) and exacer-
bation of clinical symptoms of UC. Based on real-time
PCR, we demonstrated a significant increase in E. coli in
inflammatory tissues in patients with UC compared with
the control group.
In most recent studies, microorganisms in tissue sam-
ples from patients with different IBDs have been as-
sessed using molecular methods (e.g. PCR, real-time
PCR, and FISH), which allow one to detect even trace
amounts of microbial DNA. These methods are espe-
cially useful for quantitative analysis of tissue samples
from patients with chronic inflammatory diseases. In
places where there are ongoing biochemical reactions re-
lated to the inflammatory process, reactive oxygen spe-
cies (ROS) are abundant, which has a direct influence
causing a decrease in viability of bacterial cells [28].
These reactions are very dynamic, leading to sudden
changes in bacterial populations, depending on the pre-
sence of multiple proinflammatory factors. Using me-
thods with the highest sensitivity (real time PCR) play a
key role in such a situation. The real-time PCR system
of Ott et al. [29] provides an accurate and stable method
to measure bacterial concentrations in clinical samples,
but validation of the results obtained by real-time PCR
with traditional bacterial culture methods is difficult
to perform and can generate mean differences [29].
Therefore qualitative and quantitative assessment based
solely on classical culture methods during exacerbation
of the inflammatory process in the GI tract seems insuf-
ficient. This may also explain the differences observed in
our studies.
The results presented above from our as well as other
studies point to a relation between the quantitative
changes in E. coli and the course of UC. Wohlgemuth
et al. used mouse models (129/SvEv) to try to explain
quantitative and qualitative changes within the com-
mensal microbiota during inflammation of the GI tract.
Their study showed a decrease in variability of microor-
ganisms and a strong increase in E. coli numbers during
the development of inflammation. At the same time,
they found that there was a lack of evidence directly
Figure 3 Comparison of restriction patterns of E. coli isolated from patients with active-phase UC. Results based on PFGE. P1/ECA1-
P18/ECB1 - strains isolated from UC patients (A-inflammatorily changed place, B – unchanged mucosa, reference strain - Salmonella
Braenderup H9812.
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son for exacerbation of the inflammatory process. In
fact, their conclusion was that the conditions that ac-
company acute inflammation, favor E. coli proliferation
[10].
The increase in E. coli populations probably depends
on many adaptive factors, for example, biofilm forma-
tion, synthesis of enzymes able to catalyze breakdown of
ROS, use of supportive mechanisms allowing absorptionof iron ions from the environment, and ability to acquire
iron ions by using hemoglobin from lysed erythrocytes
[10,12].
For bacteria colonizing the human GI tract, especially
Enterobacteriacae, to obtain enough iron for their cells
is difficult, owing to the fact that iron is contained in
complexes with host proteins (e.g. hemoglobin, transfer-
rin, and lactoferrin) [30]. E. coli has the ability to lyse
red blood cells, degrade hemoglobin, and acquire iron as
Table 4 Frequency of genes responsible for synthesis of
proteins for acquisition of iron ions
Number Hemolysis -
phenotypic
Gene presence
hlyA iha iroN chuA iutA ireA
P1/ECA1 [−] [−] [−] [−] [−] [−] [−]
P1/ECB1 [−] [−] [−] [−] [−] [−] [−]
P1/ECB2 [+] [+] [−] [+] [+] [−] [−]
P2/ECA1 [−] [−] [−] [+] [−] [+] [+]
P2/ECB1 [−] [−] [−] [−] [−] [−] [−]
P3/ECA1 [−] [−] [−] [+] [+] [−] [−]
P3/ECB1 [−] [−] [−] [+] [+] [+] [−]
P4/ECA1 [−] [−] [−] [+] [−] [−] [−]
P4/ECA2 [−] [−] [−] [+] [−] [−] [−]
P4/ECB1 [−] [−] [−] [+] [−] [−] [−]
P4/ECB2 [−] [−] [−] [+] [−] [−] [−]
P4/ECB3 [−] [−] [−] [+] [−] [+] [−]
P5/ECA1 [−] [−] [−] [+] [+] [−] [−]
P5/ECA2 [−] [−] [−] [−] [−] [−] [−]
P5/ECB1 [−] [−] [−] [+] [+] [−] [−]
P5/ECB2 [−] [−] [−] [−] [−] [+] [−]
P6/ECA1 [−] [−] [−] [−] [−] [−] [−]
P6/ECB1 [−] [−] [−] [−] [−] [−] [−]
P7/ECA1 [−] [−] [−] [+] [−] [+] [−]
P7/ECB1 [−] [−] [−] [+] [−] [+] [−]
P8/ECA1 [+] [+] [−] [+] [+] [−] [−]
P8/ECA2 [−] [−] [+] [−] [+] [+] [−]
P8/ECB1 [+] [+] [−] [+] [+] [−] [−]
P8/ECB2 [−] [−] [+] [−] [+] [+] [−]
P9/ECA1 [−] [−] [−] [+] [−] [+] [−]
P9/ECB1 [−] [−] [+] [−] [+] [+] [−]
P10/ECA1 [−] [−] [−] [+] [−] [−] [−]
P10/ECA2 [−] [−] [−] [+] [−] [+] [+]
P10/ECB1 [−] [−] [−] [+] [−] [+] [+]
P11/ECA1 [−] [−] [−] [+] [−] [+] [−]
P11/ECA2 [−] [−] [−] [+] [+] [+] [−]
P11/ECB1 [−] [−] [−] [+] [−] [+] [−]
P11/ECB2 [−] [−] [−] [+] [+] [+] [−]
P12/ECA1 [−] [−] [−] [+] [+] [+] [−]
P12/ECA2 [+] [+] [−] [−] [−] [−] [−]
P12/ECB1 [+] [+] [−] [+] [+] [+] [−]
P12/ECB2 [−] [−] [−] [+] [+] [−] [−]
P13/ECA1 [+] [+] [+] [−] [+] [+] [−]
P13/ECB1 [+] [+] [+] [−] [+] [+] [−]
P13/ECB2 [+] [+] [+] [−] [+] [+] [−]
P14/ECA1 [−] [−] [−] [+] [−] [−] [−]
P14/ECB1 [−] [−] [−] [+] [−] [−] [−]
Table 4 Frequency of genes responsible for synthesis of
proteins for acquisition of iron ions (Continued)
P15/ECA1 [−] [−] [−] [−] [−] [−] [−]
P15/ECB1 [−] [−] [−] [−] [−] [−] [−]
P16/ECA1 [−] [−] [−] [−] [−] [−] [−]
P16/ECA2 [−] [−] [−] [+] [−] [+] [−]
P16/ECB1 [−] [−] [−] [+] [−] [+] [−]
P16/ECB2 [−] [−] [−] [+] [−] [+] [−]
P17/ECA1 [−] [−] [−] [+] [+] [+] [−]
P17/ECB1 [−] [−] [−] [+] [+] [+] [−]
P18/ECA1 [−] [−] [−] [+] [−] [−] [−]
P18/ECB1 [−] [−] [−] [+] [−] [−] [−]
P1/ECC1 [−] [−] [−] [+] [−] [+] [−]
P1/ECC2 [+] [+] [+] [+] [+] [+] [−]
P2/ECC1 [−] [−] [+] [−] [+] [+] [−]
P3/ECC1 [−] [−] [−] [+] [+] [+] [−]
P3/ECC2 [−] [−] [−] [+] [+] [−] [−]
P4/ECC1 [−] [−] [−] [−] [+] [−] [−]
P5/ECC1 [−] [−] [−] [−] [+] [−] [−]
P5/ECC2 [−] [−] [−] [−] [−] [−] [−]
P6/ECC1 [−] [−] [−] [−] [−] [+] [−]
P7/ECC1 [−] [−] [+] [−] [+] [−] [−]
P8/ECC1 [+] [+] [−] [−] [+] [+] [−]
P8/ECC2 [−] [−] [+] [−] [+] [−] [−]
P9/ECC1 [−] [−] [−] [+] [−] [−] [−]
P10/ECC1 [−] [−] [−] [−] [−] [+] [−]
P10/ECC2 [−] [−] [+] [−] [+] [+] [−]
P11/ECC1 [−] [−] [−] [+] [+] [+] [−]
P12/ECC1 [−] [−] [−] [−] [−] [−] [−]
P12/ECC2 [−] [−] [−] [−] [+] [−] [−]
Genes studied: iroN, iutA, iha, ireA, chuA and hlyA.
+ positive result; – : negative result.
P1/ECA1–P18/ECB1: strains isolated from UC patients (A: inflammatory tissues; B:
unchanged mucosa); P1/ECC1–P12/ECC2: strains isolated from the control group.
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[12]. In our study, we noted a significant increase in -
E. coli that possessed the chuA gene, which codes for a
receptor for hemin from lysed erythrocytes. This was
confirmed in patients with UC in an inflammatory tis-
sue. Similarly, a significant relation was confirmed for -
E. coli bearing the iutA gene, which is responsible for
coding a receptor that allows absorption of iron chelated
by one of the siderophores (aerobactin) [30]. The pres-
ence of the chuA and iutA genes in E. coli correlates
with the increased numbers of bacteria assessed using
real-time PCR in inflammatory tissues where more free
iron is available. Additionally, we observed significant
differences in the presence of iroN gene in E. coli. The
iroN gene encodes a receptor that is responsible for
Figure 4 Distribution of E. coli with confirmed iroN gene. Specimens isolated from colon mucosa with inflammatory changes and unchanged
mucosa from patients with active-phase UC compared with the control group.
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http://www.biomedcentral.com/1471-230X/13/61identifying and binding siderophores (glucosylated
enterobactins), expression of which depends on the pres-
ence of iron ions in the environment [30]. The presence
of iroN gene was confirmed in 70% and 65% of E. coli
strains isolated from inflammatory and unchanged tis-
sues in UC patients, respectively, compared with 25% of
strains from the control group. Based on our present
and other previous studies [10], we can conclude that in-
creased availability of iron ions in the GI tract of pa-
tients with UC is a significant factor related to the
quantitative increase in E. coli.
Our study not only assessed E. coli quantitatively in
UC and control group patients, but also compared the
genetic profiles of the strains based on PFGE. Compara-
tive analysis of the restriction patterns confirmed high
variability among the E. coli strains. It seems that the
focal inflammatory state does not favor adhesion of a
specific type of E. coli. In 83% of cases (15/18 patients),
genetically identical E. coli were isolated from inflamma-
tory lesions compared with unchanged tissue. Different
profiles of E. coli collected from the two types of tissues
were demonstrated in only three patients. There were
no similarities between strains isolated from differentFigure 5 α-Hemolysis visible on blood agar. E. coli: P1/ECB2, P8/ECA1, P
strains: P1/ECA1, P1/ECB1, P6/ECA1, P6/ECB1, P9/ECA1, P9/ECB1 – no alphapatients. Similar confirmatory results were obtained by
Thomazini et al. [31], who used ERIC2-PCR (Enterobac-
terial Repetitive Intergenic Consensus-PCR) in their ana-
lysis of 131 E. coli strains isolated from patients with
IBD (including UC) and a control group. They demon-
strated unequivocally that there was no specific strain or
group of strains of E. coli related to UC or Crohn’s di-
sease, or in the control group. Sepehri et al. [2] have
compared E. coli strains from patients with IBD (inclu-
ding UC) and a control group, using MLST (Multilocus
Sequence Typing). Three main groups of E. coli were
drawn but no relation was found for the strains and di-
sease entity.
It is worth mentioning that so far there is no proof of
a single E. coli strain participating in the etiopatho-
genesis of UC [16]. It is more often considered that
there is an increase in E. coli populations that can bind
free iron ions by siderophores [12] and store iron intra-
cellularly [32], which allows them to inhibit the Fenton
reaction in the intestine, by eliminating iron ions and
prevention of ROS formation, and at the same time re-
ducing damage to the host tissues [28]. Furthermore,
considering the role of E. coli as an anti-inflammatory8/ECB1, P12/ECA2, P12/ECB1, P13/ECB2 – visible type alpha hemolysis,
hemolysis.
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http://www.biomedcentral.com/1471-230X/13/61and facilitating remission, there have been some studies
on E. coli Nissle as a probiotic [33].
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